Vanguard Capital Management’s Ensysce Biosciences ENSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.35K Hold
12,854
– – ﹤0.01% 4039
2026
Q2
$3.73K Hold
12,854
– – ﹤0.01% 4072
2026
Q1
$6.93K Buy
+12,854
New +$8.15K ﹤0.01% 4029

Other funds holding ENSC

Vanguard Capital Management's ENSC Position: Q3 2026 in Review

Vanguard Capital Management held its Ensysce Biosciences (ENSC) position steady in Q3 2026 at 12,854 shares worth $5.35K. The position accounts for ﹤0.01% of the portfolio, ranked #4039.

Vanguard Capital Management first reported a position in ENSC in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.93K in Q1 2026. 17 funds tracked by Wall St. Rank hold ENSC as of Q3 2026.

  • Vanguard Capital Management held 12,854 shares of Ensysce Biosciences worth $5.35K as of Q3 2026.
  • Vanguard Capital Management left its Ensysce Biosciences share count unchanged in Q3 2026.
  • Ensysce Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #4039 holding.
  • Vanguard Capital Management first reported a position in Ensysce Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Ensysce Biosciences position peaked at $6.93K in Q1 2026.
  • 17 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.